Study to Evaluate Safety and Efficacy of ASC42 Combined With ETV and PEG-IFN ?-2a in Subjects With HBV
收藏DataMed2026-07-12 收录
官方服务：
资源简介：
This is a phase2, randomized, single-blind, placebo controlled and multi-center study in adults with chronic hepatitis B virus. The study is aimed at evaluating efficacy and safety of ASC42 in combination with entecavir and pegylated interferon ?-2a in subjects with chronic hepatitis B virus.
提供机构：
ClinicalTrials.gov
